Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab)

被引:45
|
作者
Kain, S [1 ]
Copeland, TS [1 ]
Leahy, MF [1 ]
机构
[1] Fremantle Hosp, Dept Haematol, Fremantle, WA, Australia
关键词
rituximab; refractory autoimmune (acquired) haemophilia; factor VIII inhibitor;
D O I
10.1046/j.1365-2141.2002.03835_5.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:578 / 578
页数:1
相关论文
共 50 条
  • [1] The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
    D'Arena, Giovanni
    Grandone, Elvira
    Di Minno, Matteo N. D.
    Musto, Pellegrino
    Di Minno, Giovanni
    BLOOD TRANSFUSION, 2016, 14 (03) : 255 - 261
  • [2] Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)
    Ahrens, N
    Kingreen, D
    Seltsam, A
    Salama, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 244 - 245
  • [3] Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    Kasperkiewicz, M.
    Zillikens, D.
    HAUTARZT, 2007, 58 (02): : 115 - +
  • [4] Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab
    Swords, R
    Nolan, A
    Fay, M
    Quinn, J
    O'Donnell, R
    Murphy, PT
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 57 - 59
  • [5] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [6] Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?
    Mc Mahon, C
    Babu, L
    Hodgson, A
    Hayat, A
    Connell, NO
    Smith, OP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 480 - 482
  • [7] Rituximab (anti-CD20) zur Behandlung von bullösen AutoimmundermatosenRituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    M. Kasperkiewicz
    D. Zillikens
    Der Hautarzt, 2007, 58 (2): : 115 - 121
  • [8] Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)
    Fernando Pinto, Luis
    Candia, Liliana
    Garcia, Patricia
    Ignacio Marin, Juan
    Pachon, Ines
    Espinoza, Luis R.
    Marquez, Javier
    RESPIRATION, 2009, 78 (01) : 106 - 109
  • [9] Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases
    Hertl, Michael
    Zillikens, Detlef
    Borradori, Luca
    Bruckner-Tuderman, Leena
    Burckhard, Harald
    Eming, Ruediger
    Engert, Andreas
    Goebeler, Matthias
    Hofmann, Silke
    Hunzelmann, Nicolas
    Karlhofer, Franz
    Kautz, Ocko
    Lippert, Undine
    Niedermeier, Andrea
    Nitschke, Martin
    Pfuetze, Martin
    Reiser, Marcel
    Rose, Christian
    Schmidt, Enno
    Shimanovich, Iakov
    Sticherling, Michael
    Wolff-Franke, Sonja
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (05): : 366 - 374
  • [10] Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): Five cases
    Antonucci, Angela
    Negosanti, Massimino
    Tabanelli, Michela
    Varotti, Claudio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (03) : 178 - 183